Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cipher Pharmaceuticals (TSE:CPH)
TSX:CPH
RESEARCH TOOLSreports
Holding TSE:CPH?
Track your performance easily
CPH Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$5.35 - C$19.69
Previous CloseC$14.56
Volume18.02K
Average Volume (3M)77.55K
Market Cap
C$371.05M
Enterprise ValueC$306.01M
Total Cash (Recent Filing)$47.98M
Total Debt (Recent Filing)$296.00K
Price to Earnings (P/E)16.2
Beta-0.75
Next Earnings
Mar 13, 2025EPS Estimate
C$0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.90
Shares Outstanding25,588,552
10 Day Avg. Volume98,654
30 Day Avg. Volume77,545
Standard Deviation0.18
R-Squared0.09
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)4.24
Price to Sales (P/S)12.52
Price to Cash Flow (P/CF)11.10
P/FCF Ratio11.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue32.28
Enterprise Value/Gross Profit69.33
Enterprise Value/Ebitda419.19
Forecast
1Y Price Target
C$17.00Price Target Upside17.24% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Cipher Pharmaceuticals News
PremiumCompany Announcements
Cipher Pharmaceuticals Q3 2024 Results: Growth and Acquisitions
PremiumCompany Announcements
Cipher Pharmaceuticals’ Revenue Soars After Natroba Acquisition
PremiumCompany Announcements
Cipher Pharmaceuticals Announces Q3 2024 Financial Results
PremiumCompany Announcements
Cipher Pharmaceuticals Welcomes New Chief Business OfficerOptions Prices
Currently, No data available
---
Ownership Overview
1.43% Insiders
0.91% Mutual Funds
0.72% Other Institutional Investors
96.79% Public Companies and
Individual Investors
CPH FAQ
What was Cipher Pharmaceuticals’s price range in the past 12 months?
Cipher Pharmaceuticals lowest stock price was C$5.35 and its highest was C$19.69 in the past 12 months.
What is Cipher Pharmaceuticals’s market cap?
Currently, no data Available
When is Cipher Pharmaceuticals’s upcoming earnings report date?
Cipher Pharmaceuticals’s upcoming earnings report date is Mar 13, 2025 which is in 110 days.
How were Cipher Pharmaceuticals’s earnings last quarter?
Cipher Pharmaceuticals released its earnings results on Nov 07, 2024. The company reported C$0.014 earnings per share for the quarter, missing the consensus estimate of C$0.195 by -C$0.181.
Is Cipher Pharmaceuticals overvalued?
According to Wall Street analysts Cipher Pharmaceuticals’s price is currently Undervalued.
Does Cipher Pharmaceuticals pay dividends?
Cipher Pharmaceuticals does not currently pay dividends.
What is Cipher Pharmaceuticals’s EPS estimate?
Cipher Pharmaceuticals’s EPS estimate is C$0.27.
How many shares outstanding does Cipher Pharmaceuticals have?
Cipher Pharmaceuticals has 25,589,450 shares outstanding.
What happened to Cipher Pharmaceuticals’s price movement after its last earnings report?
Cipher Pharmaceuticals reported an EPS of C$0.014 in its last earnings report, missing expectations of C$0.195. Following the earnings report the stock price went down -10.682%.
Which hedge fund is a major shareholder of Cipher Pharmaceuticals?
Currently, no hedge funds are holding shares in TSE:CPH
---
Cipher Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
143.41%
12-Months-Change
Fundamentals
Return on Equity
17.98%
Trailing 12-Months
Asset Growth
69.95%
Trailing 12-Months
Company Description
Cipher Pharmaceuticals
Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Oakville, Canada.
---
CPH Earnings Call
Q3 2024
0:00 / 0:00
---
CPH Stock 12 Month Forecast
Average Price Target
C$17.00
▲(17.24% Upside)
Technical Analysis
Theratechnologies
―
Citius Pharmaceuticals
―
PAVmed
―
Rockwell Med
―
Cipher Pharmaceuticals
―
Best Analysts Covering CPH
1 Year
1 Year Success Rate
6/8 ratings generated profit
1 Year Average Return
+31.99%
reiterated a buy rating 12 days ago
Copying Justin Keywood's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +31.99% per trade.
---